Defeating cancer together: our policy priorities
We believe there are three areas the Government could prioritise to enable cancer research in academic institutions to thrive, and help us on our mission to continue making the discoveries that defeat cancer.
"We need the Government to use all available policy levers to support the sector and help cancer research in UK academic institutions thrive."
- Professor Kristian Helin, Chief Executive, The Institute of Cancer Research
"100 days in - it is vital that this new Parliament comes together to prioritise cancer research. For all of us affected by cancer, research is where hope starts, Parliament can help catalyse this hope"
- Sue Duncombe, Cancer Patient Advocate
Advocacy blog posts
The Charity Research Support Fund: An overlooked, and neglected, lifeline for UK science
Ollie Richards, Advocacy Manager at the ICR, explores how a critical element of the Government's research funding – the Charity Research Support Fund – could be reformed to help support more specialist institutions and universities to do life-saving research.
100 days in – what do we need from the Government to enable cancer research to thrive?
We’re now 100 days into the new Government and the ICR’s Advocacy Manager, Ollie Richards, outlines what academic institutions need the Government to prioritise to help us on our mission to continue making the discoveries that defeat cancer.
Latest ICR News
UK scientists create most detailed map yet of mutations that drive cancer
Scientists have created the most comprehensive map to date of the genetic mutations that fuel cancer – opening the door to extending precision treatments to thousands more patients and offering clues as to why bowel cancer rates are rising in younger people.
Why is animal research still necessary to defeat cancer?
In this feature, cancer scientists and animal research experts across The Institute of Cancer Research, London, discuss why breakthroughs gained by studying whole-body systems in animals are essential in understanding how cancer develops and behaves within a whole organism, and how to treat it effectively.
ICR scientists support promising new immunotherapy trial for advanced ovarian cancer
Scientists at The Institute of Cancer Research, London, are supporting an international clinical trial of a promising new immunotherapy treatment for advanced ovarian cancer.